Dendrimers for sustained release of compounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/14 (2006.01) A61K 47/48 (2006.01) C08G 73/00 (2006.01) C08G 83/00 (2006.01)

Patent

CA 2701291

Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compo-sitions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.

L'invention concerne des procédés et des compositions à base de dendrimères qui sont utiles pour administrer des compositions pharmaceutiques à des cellules et des tissus cibles afin de traiter des maladies oculaires comprenant la dégénérescence maculaire, la rétinopathie diabétique et la rétinite pigmentaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dendrimers for sustained release of compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dendrimers for sustained release of compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dendrimers for sustained release of compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1520637

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.